SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Calbiotech Inc. announced it bought Sacramento-area Moduline Systems Inc. for an undisclosed sum.
The Salk Institute for Biological Studies in La Jolla has appointed two veteran businessmen to its board – Alan Gold, Chairman and CEO of BioMed Realty Trust, and venture capitalist David Hale, CEO of Hale BioPharma Ventures LLC.
San Diego-based CareFusion Inc. is investing $100 million in Israeli pump maker Caesarea Medical Electronics, acquiring a 40 percent stake of the company.
San Diego-based life sciences software company Accelrys Inc. has acquired Ireland-based Qumas for $50 million in cash.
BIOTECH: Strategic Reprioritization Reduces Amount for M&A Activity
Volcano Corp. has authorized a $200 million share repurchase program — an initiative in line with advice from an activist investor who is reportedly grooming the company as an acquisition target.
HEALTH: Scripps, Kaiser, UC San Diego Have Plans For New Facilities
The completion of the $456 million Camp Pendleton Naval Hospital and the $225 million Scripps Proton Therapy Center highlighted a year in which several medical facilities, large and small, made strides toward opening.
Ligand Pharmaceuticals Inc. has grown its revenue and net income guidance, due to better-than-expected sales of its Captisol product.
Palomar Health will join the Mayo Clinic Care Network, the Escondido-based health system announced Wednesday.
Sense4Baby Inc. — a developer of a remote, wireless maternal-fetal heart rate monitoring system to perform nonstress testing for high-risk pregnancies on a smartphone or tablet — received 510(k) clearance from the U.S. Food and Drug Administration and a CE mark from the European Commission to commercialize its medical device.
San Diego-based cancer drug developer Ignyta Inc. has raised $54 million in two separate stock offerings, exceeding the company’s original target of $35 million.
San Diego-based pharmaceutical company Zogenix Inc. announced a long-term collaborative agreement with global research-and-development organization Battelle to co-market Zogenix’s DosePro needle-free drug delivery technology.
Volcano Corp. has authorized a $200 million share repurchase program — which is in line with the advice from an activist investor who is reportedly grooming the company as an acquisition target.
San Diego-based Orexigen Therapeutics Inc. is planning a $100 million offering of convertible senior notes, the company announced.
ResMed Inc., a San Diego-based medical device maker, has bought Unimedis, a distributor of equipment for treating sleep-disordered breathing operating in the Czech Republic and Slovakia.